PureTech Health PLC 2021 AR2
The report highlights PureTech's progress in 2021, including advancing its wholly-owned pipeline of seven therapeutic candidates and its founded entities. Key achievements include securing $731.9 million in funding for founded entities, generating $218.1 million in non-dilutive cash from equity sales, and advancing clinical trials for LYT-100, LYT-200, and LYT-300. On the ESG front, the company aligned its reporting with SASB and TCFD frameworks, achieved 44% gender diversity on its Board, and reduced energy consumption at its Boston headquarters by 85% compared to the 2030 Challenge baseline.
Company: PureTech Health PLC
Sector: Professional & technical services
Country: United States
Year: 2021
Type: AR2
Pages: 256
Back to company
PureTech Health PLC
Annual Report And Accounts
The report highlights PureTech's progress in 2021, including advancing its wholly-owned pipeline of seven therapeutic candidates and its founded entities. Key achievements include securing $731.9 million in funding for founded entities, generating $218.1 million in non-dilutive cash from equity sales, and advancing clinical trials for LYT-100, LYT-200, and LYT-300. On the ESG front, the company aligned its reporting with SASB and TCFD frameworks, achieved 44% gender diversity on its Board, and reduced energy consumption at its Boston headquarters by 85% compared to the 2030 Challenge baseline.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Total Waste
Women on Board
Women in Management
Employees